Clinical Trials

300 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07461818 2026-03-11

POC

5,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04712851 2026-03-10

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Phase 2 Recruiting

25 enrolled

Uterine Cervical Dysplasia

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Phase 2 Not yet recruiting

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT07454915 2026-03-09

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

138 enrolled

Uterine Cervical Dysplasia

NCT06979180 2026-03-05

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

60 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Uterine Cervical Dysplasia

NCT07429071 2026-03-04

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

70 enrolled

Uterine Cervical Dysplasia

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Phase NA Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07372248 2026-03-02

Thermal Artifact in Patients Undergoing Conization: A Clinical Study

150 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02749110 2026-02-05

PaCUDAHL-Gé

308 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Patient Compliance

NCT07390916 2026-02-05

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

300 enrolled

Phase EARLY_PHASE1 Withdrawn

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT02554344 2026-01-30

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Uterine Cervical Dysplasia

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01639820 2025-12-19

SENTICOL2

267 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07275333 2025-12-18

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

1,000 enrolled

Phase 2 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT06519994 2025-12-17

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

120 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT04098744 2025-10-02

ART-CIN_IIB

Phase 2 Recruiting

78 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06191133 2025-10-02

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Phase 1 Recruiting

24 enrolled

Phase NA Enrolling by invitation

Uterine Cervical Dysplasia

NCT06942286 2025-09-17

Primary HPV Self-Collection in Indonesia

8,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07146152 2025-08-28

Empowering Women - Shared Decision Making in Managing Cervical Precancer

138 enrolled

GynecologicOther neoplasm

Uterine Cervical Dysplasia

NCT06165614 2025-08-19

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Phase 1 Completed

17 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT07059819 2025-08-13

Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection

Phase NA Enrolling by invitation

400 enrolled

Uterine Cervical Dysplasia

NCT06086054 2025-08-05

Effect of a Childcare Resource on Cervical Cancer Prevention

Phase NA Terminated

65 enrolled

Uterine Cervical Dysplasia

NCT03429582 2025-07-17

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

1,154 enrolled

Uterine Cervical Dysplasia

NCT02140021 2025-07-14

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Phase NA Terminated

409 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06054841 2025-06-29

Reshaping Postpartum Follow-up

157 enrolled

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Eclampsia, Pre-Eclampsia, Diabetes, Gestational, Hypertension, Pregnancy-Induced

NCT05996783 2025-06-13

ScreenUrSelf

48,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06562595 2025-05-20

What is the Optimal Training Model for Cervical Awareness?

400 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03061435 2025-05-16

Vulvar-AIN

GastrointestinalGynecologic

110 enrolled

Anus Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT04278326 2025-04-20

ORGANOIDES

Phase NA Terminated

14 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Phase 2 Terminated

10 enrolled 19 charts

Phase EARLY_PHASE1 Completed

Uterine Cervical Dysplasia

NCT03196180 2025-04-08

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

13 enrolled 10 charts

Uterine Cervical Dysplasia

NCT03084081 2025-04-06

UH3

1,132 enrolled 9 charts

Phase NA Active not recruiting

Uterine Cervical Dysplasia

NCT06452004 2025-04-04

AI-DSS

600 enrolled

Phase NA Enrolling by invitation

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04915495 2025-03-21

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

400 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04226313 2025-03-19

KOPRETINA

15,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05229679 2025-03-19

HPV-based Screening Among Women 23-29 Years of Age

180,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06149598 2025-03-04

Coughing at Time of Cervical Biopsy

30 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Cough, Pain

NCT05078528 2025-02-06

Low-cost Imaging Technology for Global Prevention of Cervical Cancer

1,060 enrolled

Uterine Cervical Dysplasia

NCT05496231 2025-02-03

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Phase 1/2 Completed

1,080 enrolled 28 charts

Uterine Cervical Dysplasia, Infections

NCT05132114 2025-01-31

LLETZ-IOLI

216 enrolled

Uterine Cervical Dysplasia

NCT05391243 2025-01-31

LLETZ-MC

152 enrolled

Uterine Cervical Dysplasia

NCT03493542 2024-12-31

V501-213

Phase 3 Completed

766 enrolled 38 charts

Phase 2 Enrolling by invitation

Uterine Cervical Dysplasia

NCT06525870 2024-11-14

Trichlosil

44 enrolled

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT03721978 2024-10-17

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Phase 3 Completed

203 enrolled 34 charts

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT06598176 2024-09-19

COMBISCREEN

100 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06491888 2024-08-15

A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening

4,200 enrolled